This Week in Hearing

By This Week in HearingHealth & Fitness

This Week in Hearing episodes

October 11, 2024 237 - From OTC to Prescription Hearing Aids: Eargo Broadens Its Hearing Solution Offerings
Building on their reputation as a direct-to-consumer innovator, Eargo is now entering the prescriptive hearing aid market, offering patients and audiologists a new level of control and care with their cutting-edge devices. CEO Bill Brownie reflects on Eargo's journey, highlighting how their invisible, rechargeable devices have evolved to meet the demands of patients who want both cutting-edge technology and expert guidance of hearing professionals.
Eargo audiologist, Dr. Kim White, delves into the benefits of Eargo’s prescriptive line, designed to provide audiologists with greater control over fittings while meeting the preferences of patients seeking discreet, high-performance solutions. Together, they outline how Eargo aiming to bridge the gap between direct-to-consumer convenience and professional expertise.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
29 min
October 08, 2024 236 - The Latest Advances in Otoprotective Agents with Ting Therapeutics CEO, Dr. Jian Zuo
Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company's innovative drug candidates and how they aim to address the unmet need for hearing protection.
Zuo provides an overview of Ting Therapeutics’ preclinical research, outlining key findings on TT003 and other investigational compounds. The discussion focuses on the company's research process, detailing the progress of these drug candidates through preclinical testing and examining their potential relevance for patients at risk of hearing loss.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
30 min
October 02, 2024 235 - In-Tune: Communicating Clearly and Ethically about Hearing Loss and Cognitive Decline/Dementia
How do we communicate the link between hearing loss and cognitive decline without misleading patients? In this keynote session from the 2024 Academy of Doctors of Audiology conference, Dr. Jan Blustein dives deep into the challenge of delivering clear and ethical messages about hearing health.
She addresses the common pitfalls in public health communication, such as headlines that claim "hearing aids can slow cognitive decline by 48%," which can oversimplify complex epidemiological data and mislead patients about their personal risk and the benefits of hearing aids.
Dr. Blustein revisits the fundamentals of epidemiological risk, explaining how population-level findings can differ from individual outcomes. She also explores the concept of "prevention" and how terms like this, while technically accurate, need to be handled carefully in conversations with patients. Through interactive discussions and real-world examples, this presentation provides invaluable guidance on crafting messages that are not only accurate but also ethical and patient-centered.
Whether you’re a healthcare professional or someone interested in the science of hearing and cognitive health, this session offers a fresh perspective on communicating research findings responsibly. Dr. Blustein’s insights will help ensure that patients receive the information they need to make informed decisions about their hearing and overall well-being.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
1 hr
September 25, 2024234 - Practical Applications of Ototoxicity Monitoring: Patient Case Studies (Part 2)
Host Bob Traynor continues his conversation with Renee Lefrancois, Director of Audiology at Shoebox, on the vital role of ototoxicity monitoring. Renee explains the different types of ototoxicity, including cochleotoxicity, vestibulotoxicity, and neurotoxicity, and how early signs like hearing loss, tinnitus, and balance issues can indicate ototoxic damage.
The conversation emphasizes the global need for ototoxicity monitoring, particularly in areas with limited access to audiology services, where diseases like tuberculosis and cystic fibrosis are prevalent.
Renee shares real-world case studies, such as the use of Shoebox's technology for monitoring patients with multidrug-resistant tuberculosis (MDR-TB) and Meniere’s disease. These examples highlight how accessible tools are making a difference for both patients and clinicians, especially in remote locations. With advancements like noise monitoring during hearing tests, remote audiometry has become more accurate and practical, breaking down barriers for patients unable to attend regular appointments. The conversation concludes by looking toward the future of ototoxicity monitoring, with technology playing a growing role in clinical practice and collaboration across healthcare professionals becoming increasingly essential.
**Learn more about Shoebox here:
https://www.shoebox.md
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/

https://twitter.com/WeekinHearing
28 min
September 24, 2024 233 - Improving Access to Ototoxicity Monitoring for Patients and Clinicians (Part 1)
Ototoxicity monitoring is a vital tool for preserving hearing in patients undergoing treatments with ototoxic medications, such as those used for cancer or tuberculosis. Bob Traynor and Renee Lafrancois from Shoebox Audiometry discuss the practical applications of this monitoring and how accessible tools are making it easier for clinicians to integrate into patient care.
Renee explains the global implications of ototoxicity monitoring, especially in low-resource areas where access to audiological care is limited. This episode explores the importance of collaboration between audiologists and oncologists to ensure patients' hearing is monitored during treatment, despite logistical challenges.
Looking ahead, Bob and Renee preview a follow-up episode where they will dive deeper into case studies and specific procedures for remote ototoxicity monitoring using automated audiometry. The upcoming episode will explore how these tools are making a difference in various clinical settings.
**Learn more about Shoebox here: https://www.shoebox.md
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
24 min
September 19, 2024 232 - ADA AuDacity 2024 Featured Keynote: Innovation Update in Hearing Care
At the 2024 Academy of Doctors of Audiology conference, a panel featuring Andrew Bellavia, Steve Taddei, and David Kemp provided insights into current innovations in hearing healthcare with a focus on the integration of artificial intelligence (AI) in diagnostics, devices, and care delivery. The wide-ranging discussion began by diving into how AI-driven tools such as automated audiograms, real-ear measurements, and advanced hearing aid programming, are poised to transform the landscape of hearing care both in clinics and in ways that reach underserved regions. Then they tackled AI in hearing aids, how it is employed today, and what's coming to improve outcomes particularly in noisy situations both in prescription and consumer devices.
Stigma remains a discussion point and the panelists lent their thoughts, naming how the convergence of stylish earbuds and hearing protection is intersecting with hearing aid designs, changing mindsets and reducing hearing loss stigma. The conversation naturally turned to the present state of OTC hearing aids, if they are delivering on the promise to improve accessibility at lower prices, how the hearing care profession is affected, and how audiologists are communicating their value in the face of widespread OTC messaging. Other innovations covered include an Auracast update and the range of tools and devices to inform consumers of their noise exposure and how to protect against it.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
1 hr 16 min
September 09, 2024231 - Mark Schulman on Hearing Loss, Tinnitus & Rocking the Stage with Purpose
Join Gael Hannan as she chats with legendary drummer and keynote speaker Mark Schulman. With an impressive career spanning over 30 years, Mark has played for musical legends like Pink, Cher, and Stevie Nicks, performing for over a billion people.
Mark opens up about his journey with hearing loss and tinnitus, a challenge he has faced throughout his 30-year career. He discusses the importance of protecting your hearing, especially as a musician, and shares how his experience with his hearing aids has transformed his ability to reconnect with the sounds around him.
Mark also talks about his transition from life on tour to keynote speaking, where he emphasizes the power of attitude in overcoming obstacles. His latest book, The Attitude Equation, delves into how attitude shapes behavior and outcomes, drawing insights from interviews with top performers across various industries. This conversation offers valuable perspectives on hearing health, personal growth, and maintaining a positive outlook despite life's challenges.
**Learn more about Mark and his latest book, The Attitude Equation: https://www.markschulman.com/the-author
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/

https://twitter.com/WeekinHearing
29 min
September 03, 2024230 - Magnetic Nanoparticles: The Future of Hearing Loss Treatment? Exploring the Latest Research with Dr. Daniel Sun
This week we are joined by Dr. Daniel Sun, Director of the Division of Neurotology and Associate Professor of Otolaryngology at the University of Cincinnati College of Medicine, to discuss his pioneering research in hearing loss treatment.
Addressing the challenges of delivering large molecule medications to the inner ear, Dr. Sun introduces a novel approach using magnetic nanoparticles. These particles, guided by magnetic fields, could provide a more effective way to deliver treatments directly into the cochlea, offering new possibilities for managing sensorineural hearing loss.
Dr. Sun also explores the role of advanced MRI techniques in understanding how the brain adapts to hearing loss. This research aims to develop predictive tools to better assess which patients might benefit from cochlear implants, even after long periods of deafness. Additionally, he shares insights into new software under development that could improve cochlear implant performance, potentially enhancing outcomes for many patients.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/

https://twitter.com/WeekinHearing
30 min
August 27, 2024 229 - Inside Sony's CRE-C20 Hearing Aids: A Detailed Overview with Annie Duchen
Sony has introduced the CRE-C20, the latest addition to its line of over-the-counter (OTC) hearing aids. Building on the success of the CRE-C10, the new CRE-C20 retains the sleek, completely-in-canal (CIC) design while offering significant enhancements like a built-in rechargeable battery that delivers up to 28 hours of continuous use.
The CRE-C20 is designed for individuals with mild to moderate hearing loss who want a discreet solution. The updated Sony Hearing Control app personalizes settings for each user and offers six smart hearing profiles based on thousands of real-life audiograms. This app allows users to easily adjust sound quality and volume, ensuring the hearing aids are tailored to their specific needs. The CRE-C20 also includes Ear-to-Ear Wireless Link technology for improved noise reduction and directionality, along with an Auto Sound Analyzer that prioritizes speech clarity in noisy environments.
The CRE-C20, available from August 27th for $999.99 per pair, is positioned within the premium OTC hearing aid market. Sony offers multiple customer support options, including call, chat, text, and 1:1 appointments, available both pre- and post-purchase to assist users in managing their hearing health.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
29 min
August 20, 2024228 - Exploring Phonak’s Revolutionary Infinio Hearing Aids with Those Who Made It Happen
Host Andrew Bellavia takes us on an in-depth exploration of Phonak's latest hearing aid platform, Infinio, which features a number of benefits both for the HCP at fitting and for the end-user in daily life. The most exciting innovation is in the model named Sphere which incorporates a powerful deep neural network chip to perform speech and noise separation in an ear-worn device for the very first time. Andrew speaks with three key Phonak team members to go beyond the headlines while providing a basic overview of AI in hearing devices, and why Sphere is a seminal moment in hearing device innovation.
Christine Jones, currently Senior Director of Marketing and VP Audiology at the time Infinio was kicked off, takes us through everything new across the range of products. Henning Hasemann, Director of Deep Learning Engineering and the person who led the team that developed the AI model in Sphere, describes how they remove noise in real time while maintaining natural sound across different languages, speaking styles, and environments, naming the specific benefit to hearing impaired people v. classical acoustic methods employed in hearing devices today. Then Stefan Launer, VP of Audiology and Health Innovation, provides additional context on the broader implications of this innovation for the future of hearing care, offering a glimpse into how AI and sophisticated engineering are set to redefine the possibilities in hearing technology across a continuum of needs.
Interested listeners can also check out the launch announcement for the Infinio hearing aid line up here
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
https://www.linkedin.com/company/this-week-in-hearing/

https://twitter.com/WeekinHearing
51 min

About This Week in Hearing

From the publisher's feed

The place where subject matter experts across the "World of Hearing" come together to discuss all things hearing health, hearing aids, hearables, consumer audio, and everything in-between.